Concepedia

Bhagyashree Bhagwat

BB

Statistics

Publications

6

Citations

369

H-Index

6

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bhagyashree Bhagwat is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, oncology, and immunoregulation.

Publications per year

2003–2024

6

Publications

6

Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening

Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer et al. · Molecular Cancer Therapeutics · 2011 · 171 citations · Full text

, , +17

Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells

Selvakumar Sukumar, Douglas C. Wilson, Ying Yu et al. · Cancer Research · 2017 · 63 citations

, , +17

p23 enhances the formation of the aryl hydrocarbon receptor–DNA complex

Premnath Shetty, Bhagyashree Bhagwat, William K. Chan · Biochemical Pharmacology · 2003 · 50 citations

, , +9

Establishment of engineered cell-based assays mediating LAG3 and PD1 immune suppression enables potency measurement of blocking antibodies and assessment of signal transduction

Bhagyashree Bhagwat, Holly Cherwinski, Manjiri Sathe et al. · Journal of Immunological Methods · 2018 · 50 citations · Full text

, , +17

Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models

Hangyi H. Yan, Bhagyashree Bhagwat, David Sanden et al. · Toxicology and Applied Pharmacology · 2019 · 23 citations

, , +4

1–5 of 6